NM_001144013.2:c.5011G>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001144013.2(RGPD3):c.5011G>A(p.Gly1671Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,611,670 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144013.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151974Hom.: 0 Cov.: 27 show subpopulations
GnomAD2 exomes AF: 0.0000601 AC: 15AN: 249640 AF XY: 0.0000370 show subpopulations
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1459696Hom.: 0 Cov.: 40 AF XY: 0.0000165 AC XY: 12AN XY: 726156 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151974Hom.: 0 Cov.: 27 AF XY: 0.0000270 AC XY: 2AN XY: 74200 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5011G>A (p.G1671S) alteration is located in exon 21 (coding exon 21) of the RGPD3 gene. This alteration results from a G to A substitution at nucleotide position 5011, causing the glycine (G) at amino acid position 1671 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at